Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 9Phase 3 3Phase 2/3 3Phase 1/2 3Phase EARLY_PHASE1 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Endocrine 1

Conditions

Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

pembrolizumab 222Carboplatin 216Cisplatin 204Paclitaxel 181Gemcitabine 148Docetaxel 125Capecitabine 114Dexamethasone 102Cyclophosphamide 102Pemetrexed 101Specimen Handling 99Magnetic Resonance Spectroscopy 97Oxaliplatin 95Radiotherapy 94Doxorubicin 90Fluorouracil 87Bevacizumab 82Nivolumab 73Leucovorin 72Rituximab 70durvalumab 66Vincristine 66Lenalidomide 64Etoposide 61atezolizumab 59Radiation 59Irinotecan 59130-nm albumin-bound paclitaxel 56Prednisone 55Letrozole 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × IFL protocol × 1 year × Clear all
NCT07595913 2026-05-19

A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 3 Not yet recruiting
240 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT03803553 2026-05-01

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Massachusetts General Hospital

Phase 3 Recruiting
400 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05008809 2025-12-12

AIO-KRK-0418

Charite University, Berlin, Germany

Phase 3 Recruiting
507 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡